Monday, November 29, 2021

NEWS

WHO describes global access to insulin as alarming

OMS, insulina, acceso

WHO describes global access to insulin as alarming

Geneva, Nov 13 (Prensa Latina) The World Health Organization (WHO) on Thursday described the situation with insulin as alarming, due to high prices, scarce availability, monopolization of production and weak health systems.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

The scientists who discovered the drug 100 years ago refused to benefit from its discovery and sold the patent for less than one euro, WHO Director-General Tedros Adhanom Ghebreyesus denounced in a report.

Unfortunately, this gesture of solidarity was overtaken by a multimillion-dollar business that created enormous access gaps, the authority pointed out.

In the document, which was released in advance for the celebration of the International Diabetes Day next Sunday, health authorities regretted that the change in the global insulin market imposes an unsustainable financial burden on lower-income countries.

In general, human insulin is as effective as synthetic analogs, but the latter are at least 1.5 times more expensive than the former, and in some nations three times more, the WHO said.

It pointed to three multinationals controlling more than 90 percent of the drug market, leaving little room for competition for sales from those smaller companies, it said.

He said that the drug is causing kidney damage, blindness and limb amputation.

WHO data show that diabetes is on the rise in low- and middle-income countries, when consumption is not keeping pace with the growing burden of the disease.

jg/abo/mem/znc

RELATED
ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.